XML 30 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Equity
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Equity Equity
The tables below provide a roll forward of equity.
Common Stock
In millions, shares in thousandsSharesAmountAdditional paid in capitalRetained earningsAccumulated
other
comprehensive
income (loss)
Treasury stockTotal Equity
Balance at December 31, 202243,228 $0.4 $153.0 $1,007.7 $(46.8)$(416.0)$698.3 
Net income (loss)— — — 50.7 — — 50.7 
Other comprehensive income (loss)— — — — 8.0 — 8.0 
Common stock issued139 — — — — — — 
Exercise of stock options, net41 — 2.2 — — — 2.2 
Tax payments related to vested restricted stock units— — — — — (4.5)(4.5)
Share repurchase program— — — — — (33.4)(33.4)
Share-based compensation plans— — 3.7 — — 0.7 4.4 
Balance at March 31, 202343,408 $0.4 $158.9 $1,058.4 $(38.8)$(453.2)$725.7 
Common Stock
In millions, shares in thousandsSharesAmountAdditional paid in capitalRetained earningsAccumulated
other
comprehensive
income (loss)
Treasury stockTotal Equity
Balance at December 31, 202143,102 $0.4 $136.3 $796.1 $13.1 $(272.1)$673.8 
Net income (loss)— — — 60.8 — — 60.8 
Other comprehensive income (loss)— — — — (10.1)— (10.1)
Common stock issued42 — — — — — — 
Exercise of stock options, net36 — 0.4 — — — 0.4 
Tax payments related to vested restricted stock units— — — — — (1.8)(1.8)
Share repurchase program— — — — — (40.4)(40.4)
Share-based compensation plans— — 2.9 — — 0.5 3.4 
Balance at March 31, 202243,180 $0.4 $139.6 $856.9 $3.0 $(313.8)$686.1 
Accumulated other comprehensive income (loss)
Three Months Ended March 31,
In millions20232022
Foreign currency translation
Beginning balance$(45.8)$18.4 
Net gains (losses) on foreign currency translation10.5 (16.6)
Gains (losses) on net investment hedges— 1.7 
Less: tax provision (benefit)— 0.4 
Net gains (losses) on net investment hedges— 1.3 
Other comprehensive income (loss), net of tax10.5 (15.3)
Ending balance$(35.3)$3.1 
Derivative instruments
Beginning balance$(1.4)$(2.1)
Gains (losses) on derivative instruments(3.0)8.3 
Less: tax provision (benefit)(0.7)2.0 
Net gains (losses) on derivative instruments(2.3)6.3 
(Gains) losses reclassified to net income(0.3)(1.5)
Less: tax (provision) benefit(0.1)(0.4)
Net (gains) losses reclassified to net income(0.2)(1.1)
Other comprehensive income (loss), net of tax(2.5)5.2 
Ending balance$(3.9)$3.1 
Pension and other postretirement benefits
Beginning balance$0.4 $(3.2)
Other comprehensive income (loss), net of tax— — 
Ending balance$0.4 $(3.2)
Total AOCI ending balance at March 31$(38.8)$3.0 
Reclassifications of accumulated other comprehensive income (loss)
Three Months Ended March 31,
In millions20232022
Derivative instruments
Currency exchange contracts (1)
$(0.2)$0.2 
Natural gas contracts (2)
0.5 1.3 
Total before tax0.3 1.5 
(Provision) benefit for income taxes(0.1)(0.4)
Amount included in net income (loss)$0.2 $1.1 
______________
(1) Included within "Net sales" on the condensed consolidated statement of operations.
(2) Included within "Cost of sales" on the condensed consolidated statement of operations.
Share Repurchases
On July 25, 2022, our Board of Directors authorized the repurchase of up to $500 million of our common stock, and rescinded the prior outstanding repurchase authorization with respect to the shares that remained unused under the prior authorization. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market prevailing conditions and other factors, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
During the three months ended March 31, 2023 and 2022, we repurchased $33.4 million, inclusive of $0.2 million in excise tax, and $40.4 million in common stock, representing 449,475 and 610,447 shares of our common stock at a weighted average cost per share of $73.86 and $66.26, respectively. At March 31, 2023, $411.5 million remained unused under our Board-authorized repurchase program.